Safety and Feasibility of Adjunct Autologous Cord Blood Stem Cell Therapy during the Norwood Heart Operation

Scientists detailed a Phase I, open label safety and feasibility trial of autologous cord blood stem cells therapy via a novel blood cardioplegia-based intracoronary infusion technique during the Norwood procedure in neonates with antenatal diagnosis of hypoplastic left heart syndrome.